Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment

The past two decades have brought many important advances in our understanding of the hereditary susceptibility to cancer. Numerous studies have provided convincing evidence that identification of germline mutations associated with hereditary cancer syndromes can lead to reductions in morbidity and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PeerJ
Hlavní autoři: Vysotskaia, Valentina S., Hogan, Gregory J., Gould, Genevieve M., Wang, Xin, Robertson, Alex D., Haas, Kevin R., Theilmann, Mark R., Spurka, Lindsay, Grauman, Peter V., Lai, Henry H., Jeon, Diana, Haliburton, Genevieve, Leggett, Matt, Chu, Clement S., Iori, Kevin, Maguire, Jared R., Ready, Kaylene, Evans, Eric A., Kang, Hyunseok P., Haque, Imran S.
Médium: Artigo
Jazyk:Inglês
Vydáno: PeerJ Inc. 2017
Témata:
Genomics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5326550/
https://ncbi.nlm.nih.gov/pubmed/28243543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.3046
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky